Abstract
In the generation of a traditional immune response against invading pathogens, innate cells guide T cells by programming their differentiation. However, here we demonstrate that αβ T cells have an essential role in priming innate immunity in the lung after Staphylococcus aureus enterotoxin A (SEA) inhalation. We found that SEA induces waves of cellular activation, cytokine production, and migration into the lung tissue and airways. However, this innate response was completely inhibited in the absence of αβ T cells. Specifically, we found that interleukin (IL)-17A was required for the recruitment of neutrophils and monocytes into the lung. The cellular source of IL-17A was γδ T cells, which increased their IL-17A production following SEA but only in an αβ T-cell-dependent manner. Thus, rapid T-cell activation orchestrates innate immunity and may be a new point of therapeutic intervention for acute lung injury.
Similar content being viewed by others
Introduction
During infection, pathogens stimulate pattern-recognition receptors (PRRs) on innate cells inducing the expression of costimulatory molecules and pro-inflammatory cytokines.1, 2 The activated innate cells process and present antigen to T cells, resulting in protective immunity. However, some pathogens also release superantigenic enterotoxins, which have the unique ability to bypass antigen processing and presentation by directly stimulating αβ T cells based on T-cell receptor (TCR) Vβ chain expression.3 Staphylococcus aureus enterotoxins exemplify this process, but how they are capable of impacting innate cells in the absence of direct receptor engagement remains unclear. For example, granulocytes such as neutrophils and mast cells are recruited into the lung, and such cellular infiltration has been observed with enterotoxin challenge in mice. This is thought to model the hallmarks of either human asthma (in the case of S. aureus enterotoxin B)4 or acute lung injury (in the case of S. aureus enterotoxin A (SEA)).5 In addition, evidence is emerging that enterotoxins can impact human nasal-associated lymphoid tissue6 based on the presence of S. aureus-specific immunoglobulin E antibodies in atopic patients,7 the colonization of nasal polyps by S. aureus,8 TCR Vβ T-cell expansion in bronchoalveolar lavage (BAL) from asthmatic patients,9, 10 and toxic shock observed after endonasal surgery.11 Thus, it appears that when T cells are stimulated by S. aureus enterotoxins, they can trigger long lasting and perhaps dangerous immune responses. In fact, recent data suggest a correlation between intestinal colonization with S. aureus strains producing enterotoxins and sudden unexpected death in infancy.12, 13 Therefore, a perplexing facet of enterotoxin disease pathogenesis is determining how a T cell stimulated by enterotoxins induces multiple aspects of innate immunity with sustained power and across many different innate cell types.
In this report, we have begun to elucidate the mechanism through which enterotoxin-stimulated αβ T cells mediate immunity in the lung. Our data demonstrates that the rapid stimulation of αβ T cells, both CD8+ and CD4+, induces a powerful innate response by initiating innate cell recruitment into the lung followed by their activation. This includes an increase in neutrophils and monocytes, as well as natural killer (NK) cells, in both lung tissue and airways. As seen in infectious disease models,14, 15 IL-17A was needed for neutrophil recruitment after intranasal enterotoxin challenge, and we found that IL-17A was produced largely by Vγ1−Vγ2− γδ T cells. Rather than enterotoxins directly stimulating γδ T cells, we demonstrate that lung γδ T cells completely relied on αβ T cells to produce IL-17A. Thus, S. aureus enterotoxins induce αβ T-cell activation, which launches a sustained innate immune response that relies on a specific cytokine network and results in pulmonary inflammation.
Results
T-cell-mediated NK cell recruitment
To investigate interactions between enterotoxin-stimulated αβ T cells and cells of the innate immune system, we performed kinetic studies following intranasal SEA challenge of wild-type (WT) C57BL/6 mice. As SEA stimulates TCR Vβ3T cells through an major histocompatibility complex (MHC) II-dependent process,16 we predicted that clonal expansion of these cells would precede innate cell accumulation in lung airways. However, we found that NK cells appeared first in the BAL after SEA challenge (Figure 1a). These data suggested that perhaps SEA might activate NK cells independently of T cells. To test this notion, TCR βδ−/− mice, which lack both αβ and γδ T cells, were challenged with SEA, and our results showed that SEA administration significantly increased NK cell numbers in WT but not TCR βδ−/− mice (Figure 1b). Thus, while NK cell accumulation in the BAL was T-cell-dependent, our results did not exclude the possibility that NK cells could influence the overall T-cell response. Interferon (IFN)-γ is one of the primary cytokines produced by NK cells,17 and in vivo the presence of IFN-γ in BAL fluid is used as a biomarker of lung injury.18, 19 Therefore, to examine whether NK cell–derived IFN-γ positively regulated the αβ T-cell response, we used monoclonal antibodies to deplete NK cells 24 h before SEA challenge. We found that NK cell depletion (Figure 2a) did not affect IFN-γ levels in BAL fluid at 40 h and was only slightly lower at 64 h (Figure 2b). However, IFN-γ was reduced to background levels when TCR βδ−/− mice were challenged with SEA (Figure 2c). These data suggest that NK cells are neither the primary source of IFN-γ present after SEA nor required to induce IFN-γ production by alternative sources. As T cells themselves can be a source of IFN-γ, we addressed the reciprocal possibility: is T-cell-derived IFN-γ responsible for shaping the NK cell response? We isolated splenic T cells from IFN-γ−/− mice and WT controls and transferred 106 cells into TCR βδ−/− mice 1 day before SEA challenge. Our results showed that NK cell accumulation (Figure 2d,e) and IFN-γ levels in the BAL were rescued (Figure 2f) when T-cell-deficient mice were reconstituted with WT cells. Importantly, we demonstrated that IFN-γ−/− T cells were sufficient to rescue NK cell accumulation in the BAL despite the significantly reduced total levels of IFN-γ in the BAL fluid (Figure 2d,f). Thus, while NK cell mobilization into lung following SEA preceded that of T cells, their accumulation was dependent on the presence of T cells but independent of the ability of those T cells to produce IFN-γ.
Early appearance of monocytes and neutrophils
As we found that NK cell recruitment was T-cell-dependent, we hypothesized that other innate cells known to be involved in acute lung injury could be impacted by the presence or absence of T cells. As monocytes and neutrophils are among the earliest cells recruited into the lung after acute injury,20, 21 we tested whether these cells were equally recruited to SEA-induced lung inflammation in WT and TCR βδ−/− mice. Eight hours after SEA challenge, monocytes (Ly6G− 7/4hi) and neutrophils (Ly6Ghi 7/4hi)22, 23 were significantly increased in the lung tissue (Figure 3a,b (upper panels)). Monocytes upregulated MHC II, which represents a necessary step in their differentiation to macrophages, when exposed to SEA ( Supplementary Figure S1 online). This increase was dependent on the presence of T cells as the percentage and absolute numbers of monocytes and neutrophils did not change in TCR βδ−/− mice following SEA administration (Figure 3a,b (lower panels)). Moreover, we found that monocyte function was significantly impaired in the absence of T cells based on the failure of lung-resident monocytes to upregulate tumor-necrosis factor (TNF) production compared with vehicle-treated controls (Figure 3c,d). Thus, pulmonary inflammation can be orchestrated by a T-cell-specific response even in the absence of any known PAMPs (pathogen-associated molecular patterns) or factors that directly induce innate cell activation.
Based on these data, we tested whether αβ or γδ T cells alone were responsible for inducing the innate response. To test this idea, we compared SEA responses in WT and TCR β−/− or TCR δ−/− mice. Our results indicated that the recruitment of Ly6G− 7/4hi monocytes and Ly6Ghi 7/4hi neutrophils was entirely dependent upon the presence of TCR β chain–bearing T cells, with no apparent role for γδ T cells ( Supplementary Figure S2 online). Thus, recruitment of monocytes and neutrophils into lung after SEA challenge was dependent upon αβ T cells but did not explain what factors were responsible for recruitment.
Rapid T-cell activation before innate cell recruitment
As innate cell recruitment and activation occurred within a few hours of SEA challenge, we reasoned that if αβ T cells were influencing innate cell recruitment, T-cell activation must occur before this time. Therefore, we examined the kinetics of αβ T-cell activation following SEA challenge. Within 1 h, the vast majority of Vβ3 bearing T cells in the lung-draining mediastinal LN upregulated CD69, and by 5 h, they were also CD25+ (Figure 4). This was the case for both the CD8+ and CD8− cells (which we presume to largely be CD4+ T cells). Strikingly, similar results were observed in the spleen, supporting the notion that acute lung injury may be initiated locally but rapidly manifest systemically. As both CD8+ and CD4+ T cells were activated following SEA administration, we used depleting antibodies to test if one subset or the other was primarily involved in mediating innate cell recruitment into the lung. Monoclonal antibodies 2.43 and GK1.5 were administered intraperitoneally 2 days before treatment with SEA to deplete CD8+ and CD4+ T cells, respectively. Unlike TCR β−/− mice, we found no defect in neutrophil or monocyte recruitment in the absence of CD8+ or CD4+ T cells (Supplementary Figure S3a,b online). Thus, either CD8+ or CD4+ T cells are sufficient to drive innate cell recruitment into the lung. However, we were surprised to find a reduction in the percentage of monocytes producing TNF when either CD8+ T cells or CD4+ T cells were depleted (Supplementary Figure S3c online). Although not reduced to the level of vehicle-treated controls, the reduction in TNF was particularly dramatic in CD4-depleted mice and less so in the CD8-depleted group. Thus, our data implicates a role for CD4+ T cells in maximizing monocyte function in the lung following SEA.
T cells are known producers of inflammatory cytokines, and once activated, they are a prominent source of IFN-γ and also TNF. Both of these cytokines are present in the inflammatory mileau of the lung following SEA and could function as a type of danger signal. To test whether either cytokine was required to mediate innate cell recruitment into the lung, we subjected IFN-γ−/− and TNF−/− mice to intranasal SEA challenge in comparison to WT controls. However, we found that neither IFN-γ−/− nor TNF−/− mice had any defect in monocyte or neutrophil recruitment ( Supplementary Figure S4 online), suggesting that alternative inflammatory molecules mediated the recruitment process.
IL-17A blockade suppresses neutrophil and monocyte recruitment
Cellular recruitment into the lung relies on the action of cytokines and chemokines. Particularly, IL-17A has been shown to have a dominant role in neutrophil recruitment to sites of inflammation.24 To answer whether IL-17A was involved in innate cell recruitment into the lung following SEA, we antagonized IL-17A or IL-17E (also known as IL-25) with neutralizing monoclonal antibodies.25 As expected, treatment with control immunoglobulin G permitted neutrophil recruitment into the lung after SEA challenge (Figure 5). However, IL-17A blockade prevented an increase in the percentage and total numbers of neutrophils at 8 h. Recruitment of monocytes into the lung was also dependent, at least partially, on IL-17A and IL-17E as neutralizing either cytokine reduced the percentages of monocytes in the lung ( Supplementary Figure S5 online). Thus, IL-17A had a key role in facilitating recruitment of neutrophils and monocytes into lung after SEA challenge.
αβ and γδ T cells cooperate to facilitate IL-17A secretion
Next we sought to determine the cellular source of IL-17A following SEA challenge. Due to the rapidity of the responses against SEA, we reasoned that it would be unlikely for αβ T cells to have enough time to differentiate into IL-17A-producing cells. Secondly, when clonally expanded lung T-cell populations were re-stimulated in vitro, they made high amounts of IFN-γ and TNF but very little IL-17A (not shown). Thus, while IL-17A had a role, its source was unlikely to be αβ T cells. Therefore, not surprisingly, when lung tissue was isolated 6 h post SEA challenge to examine IL-17A production, neither CD8+ nor CD8− TCRβ+ cells made IL-17A ( Supplementary Figure S6a online, left). Interestingly, a significant amount of IL-17A was found in the TCRβ− fraction of the total CD3+ cells. Further analysis revealed that the IL-17A producers were CD8- TCRδ+ T cells ( Supplementary Figure S6a online, right). We then compared the ability of γδ T cells to produce IL-17A following SEA challenge vs. vehicle-treated controls and found a significant upregulation in the percentage of IL-17A-producing γδ T cells in SEA-challenged mice (Figure 6a). Although some γδ T cells have the capacity to produce IL-17A in the absence of TCR engagement (i.e., following in vitro culture with phorbol myristate acetate (PMA)/ionomycin), IL-17A producers were present in the lung even in the absence of mitogen ( Supplementary Figure S6a online; gray histogram vs. dotted line), 6a and 6b). This suggested that γδ T cells were constitutively producing IL-17A early after SEA challenge. Considering the known differences in cytokine production by individual subsets of γδ T cells,26 we examined which subset of γδ T cells was being activated using antibodies specific for individual Vγ TCRs. Using antibodies against Vγ1 and Vγ2 allowed us to identify three populations of γδ T cells: Vγ1+, Vγ2+, and Vγ1−Vγ2−. When we gated on the population of CD44highIL-17+ γδ T cells induced by SEA administration, we found that between multiple experiments about 80% of the total lung γδ T cells lacked expression of Vγ1 and Vγ2 (Figure 6c). Based on the restricted anatomical localization of γδ T cells, it is likely that these cells utilize the Vγ4 TCR.27 However, when we analyzed each individual subset for their ability to produce IL-17A after SEA challenge, we found that both Vγ2+ and Vγ1−Vγ2− γδ T cells significantly increased their overall level of IL-17A production compared with vehicle-treated controls (Figure 6d,e). Thus, we have identified a previously unappreciated role for γδ T cells as producers of IL-17A in the orchestration of immunity following exposure to SEA.
Based on our findings thus far, we hypothesized that αβ T cells were required to trigger IL-17A production by γδ T cells. To test this idea, we challenged TCR β−/− vs. WT mice with SEA and asked whether γδ T cells could effectively increase IL-17A production in the absence of αβ T cells. We gated on Thy1.2+CD3+TCRδ+ lung tissue cells and found a significant increase in the percentage of γδ T cells producing IL-17A in mice challenged with SEA, both with and without PMA/ionomycin (Figure 6a,b). On the other hand, γδ T cells from TCR β−/− mice failed to constitutively upregulate IL-17A production (media) in the SEA-treated group relative to the vehicle control-treated mice even though they effectively responded to PMA/ionomycin (Figure 6a,b). However, depletion of neither CD8+ nor CD4+ T cells alone significantly altered IL-17 production by γδ T cells (Supplementary Figure S3d online). Thus, in a pattern similar to all of the innate cells examined thus far, αβ T cells, either CD8+ or CD4+, were required to initiate the response of γδ T cells, which included the production of IL-17A.
Nevertheless, it was difficult to reconcile how we observed neutrophil recruitment in the absence of γδ T cells (Supplementary Figure S3a,d online). Specifically, if γδ T cells supply IL-17A, how could neutrophil recruitment occur in TCRδ−/− mice? As we found that IL-17A production was responsible for neutrophil recruitment (Figure 5), we considered the possibility that IL-17A production was compensated for by other cells when γδ T cells were absent. Therefore, we further examined IL-17 production in TCRδ−/− mice and found that after SEA challenge, CD3+CD8-TCRδ− cells produced high levels of IL-17A, demonstrating a strong compensatory effect within TCRδ−/− mice (Supplementary Figure S6b,c online). These cells expressed CD25 and, similar to γδ T cells, were capable of producing IL-17A both directly ex vivo and in response to mitogen. Therefore, the critical role of IL-17A production following SEA challenge was further illustrated by the ability of αβ T cells to produce IL-17A and compensate for the lack of γδ T cells in order to mediate neutrophil recruitment.
Discussion
The concept of pattern recognition formulated by late Charles Janeway Jr. has proven to be prophetic.28 Specifically, ligation of PRR on innate cells induces cellular activation, thus allowing innate immune cells to direct adaptive immunity.1, 29 However, in some cases, this canonical process is subverted, and T-cell activation occurs in the absence of PRR engagement. Here we show that when such T-cell responses, as initiated by exposure to SEA, precede innate immunity, they can control the initiation and magnitude of the ensuing innate immune response. We provide evidence that this process begins with rapid αβ T-cell stimulation (Figure 4). The αβ T cells then initiate innate cell recruitment into the lung tissue and cytokine synthesis, which ultimately results in waves of immune cells entering the airways (Figures 1, 2, 3). In this model, neutrophil and monocyte recruitment into the lung is dependent on IL-17A (Figure 5), and innate-like γδ T cells are able to synthesize IL-17A only when αβ T cells are present (Figure 6). Thus, αβ T cells can spring effective innate immunity.
An important event observed in our studies was the speed with which the SEA-specific T cells became activated (Figure 4). Although pulmonary infectious disease models demonstrate T-cell activation over a period of days, our results showed systemic T-cell activation within 1 h. This is likely an outcome of superantigen binding to MHC II followed by bridging the TCR with no need for Ag processing.30 Interestingly, the rapid increase of CD69 and CD25 did not translate into clonal expansion until days after S. aureus enterotoxin challenge (Figure 1a). In fact, we were surprised to identify so many immunological parameters occurring before αβ T-cell expansion, which were nonetheless dependent upon the presence of T cells themselves. For example, the expansion of NK cells in the lung was T-cell-dependent. On the other hand, while NK cell function can foster T-cell differentiation in certain infection models,31 NK cells seemed to have little impact on T-cell function following SEA. Thus, the role of NK cells in SEA-induced lung injury is still unknown. Neutrophils and monocytes also required T-cell activation in order to accumulate in the lung. Even TNF synthesis by recruited monocytes was dependent upon T cells, especially CD4+ T cells (Supplementary Figure S3c online), and the magnitude of TNF production was particularly striking. However, it is possible, and perhaps likely, that multiple T-dependent mechanisms are responsible for the waves of innate cell recruitment that occur in the given time frame, which could explain the approximate 30-h delay in NK cell recruitment into the lung following neutrophils and monocytes. Taken together, our data demonstrates that T-cell activation can guide early innate cell recruitment and activation, and the importance of these findings may help understand the mechanism of toxic shock syndrome and severe food poisoning in patients with S. aureus enterotoxin exposure. Although it is clear that T cells produce cytokines in response to S. aureus enterotoxins, perhaps more attention should be paid to the role innate cells have during assembly of the cytokine storm,32 which could ultimately enhance the development of therapeutics against toxic shock.
An observed outcome of the cytokine storm was rapid cell recruitment into the lungs, and we focused our studies on a likely list of potential candidates. TNF was a clear possibility as TNF release occurs rapidly after T-cell activation.33 However, neither TNF nor IFN-γ were responsible, leaving cytokines that were most likely not synthesized by recently activated naive T cells as the best contenders. As such, IL-17A can mediate the recruitment of neutrophils into the lung.34 In recent years, numerous mouse models have been used to demonstrate the requirement for IL-17A to drive neutrophil recruitment into sites of inflammation, including the lung.15, 26, 35 Our results showed that IL-17A was detected directly ex vivo in non-αβ TCR T cells ( Supplementary Figure S6a online), and similar to Mycobacterium tuberculosis (TB) and Listeria monocytogenes infection, we found that γδ T cells were specifically responsible for IL-17A production.14, 36 Interestingly, using Bacillus subtilus to model another form of lung inflammation termed hypersensitivity pneumonitis, Simonian et al.37 found that CD4+ T cells could compensate for the loss of IL-17A-producing γδ T cells in TCRδ−/− mice by increasing their production of IL-17A. A comparison between SEA and TB, a pathogen of the lung, raises several interesting points. For one, TB infection occurs over weeks in a chronic fashion that is dramatically different from the acute response observed after enterotoxin exposure. Yet in both inflammatory settings, IL-17A mediates neutrophil recruitment into the lung, thus leading to pathology. A second interesting similarity between the two systems is the ability of IFN-γ to counteract the action of IL-17A both after infection38 and after enterotoxin.5 Thus, while the chronic and acute inflammatory systems are very different, there is a heavy reliance on lung γδ T cells to trigger inflammation. Future studies are required to determine whether the response of the γδ T cells following SEA depends on a similar cytokine milieu, particularly IL-2 responsiveness, as is true after TB infection.39 As IL-2 is released early after TCR ligation, we postulate that T-cell-derived IL-2 may be an unappreciated bridge to stimulating the innate immune system. Although others have shown that IL-2 has an inhibitory effect on CD4+ Th17 (T helper type 17) cells, IL-2 can have a positive role on the survival and proliferation of γδ T cells.40, 41 Ultimately, understanding how IL-17A is induced in γδ T cells following SEA is of particular interest as the upregulation of IL-1β and, to a lesser extent, IL-18 and IL-23p19, was also detected by real-time PCR following SEA (Supplementary Figure S7 online). IL-1β is likely involved as it remained upregulated in TCR δ−/− mice but not TCR β−/− mice. In total, manipulating both arms of the immune system with combinatorial therapy may impede acute inflammatory reactions that we contend rely on T-cell activation as well as innate cell function. For example, inhibition of IL-2 and IL-17A would block early neutrophil and monocyte recruitment while IL-2 neutralization could impede T-cell expansion and activation. In contrast to other translational approaches, which focus on a major cytokine from either the innate or adaptive arm of the immune response, such combinatorial therapy could further hinder compensatory efforts of the immune system as a key cytokine from both arms would be inhibited.
A perplexing question raised by our findings is how does a T-cell response induce cell recruitment into the lung via IL-17A in just hours, specifically without the presence of a known PAMP. Although one can never definitively state that the administered SEA is free of any contaminating products, the lack of a response in TCR βδ−/− mice strongly suggests a lack of any PAMPs known to activate innate cells independently of T cells. In several models, TLR stimulation is known to trigger IL-17A production, typically through the action of IL-1, IL-23, and other factors.42 One example is a human cell culture model of mycobacterium infection where IL-17A synthesis is dependent on TLR4 and dectin-1 expression.43 In vivo responses to Neisseria gonorrhoeae infection depend on TLR4 for IL-17A production,44 and our previous data support this idea as responses to lipopolysaccharide helped expand and maintain Th17 cells.45 This concept is also not limited to cases of infection as TLR6 stimulation mediates protective IL-17A responses counteracting lung pathology in an asthma mouse model.46 Thus, evidence that IL-17A production is initiated by PRR stimulation is abundant. Our data, however, showed that direct αβ T-cell stimulation also triggers early IL-17A synthesis, but perhaps surprisingly by γδ T cells. Interestingly, we found no evidence that intranasal SEA provoked Th17 differentiation as the expanded BAL Vβ3+ T cells produced IFN-γ and TNF but not IL-17A (S. Kumar and A. Vella unpublished data). In this way, one could liken SEA stimulation of T cells to PRR stimulation of innate cells. Importantly, both situations result in analogous outcomes, such as cellular activation, the release of cytokines and chemokines, and recruitment of cells into solid organs.
In sum, our data support the notion that enterotoxins can trigger T-cell-dependent innate immunity and suggest that blocking cytokines with a penchant for adaptive and innate cells might foster stronger inflammation abatement in vivo.
Methods
Mice. C57BL/6 mice, IFN-γ−/−, TNF-/-, TCRβ−/−, TCRδ−/−, and TCRβδ−/− mice were purchased from Jackson Laboratories (Bar Harbor, ME) and used between 7–14 weeks of age. All mice were maintained in the Central Animal Facility at the University of Connecticut Health Center in accordance with federal guidelines.
Immunization. SEA was purchased from Toxin Technology (Sarasota, FL). According to the certificate of analysis provided by the manufacturer, the level of endotoxin was less than an endotoxin unit per mg by LAL assay. Mice were anesthetized with isoflurane (Vedco, Saint Joesph, MO) in a vaporizing chamber (Vaporizer Sales and Service, Rockmart, GA). After anesthetization, 1 μg of SEA diluted in 50 μl of balanced salt solution (BSS) or BSS alone (vehicle) was pipetted on the nostrils (intranasal route) of mice, and this volume was inhaled instantly.
Antibodies and cytokine assays. Anti-mouse IL-17A and anti-mouse IL-17E monoclonal antibodies were a kind gift from Amgen (Thousands Oaks, CA). Antibodies for flow cytometer were purchased from BD Bioscience (San Jose, CA): CD3e (500A2), CD4 (L3T4, GK1.5), CD8 (53-6.7), TCRVβ3 (KJ25), TCRδ (GL3), TCRβ (H57-597), TCR Vγ2 (UC3-10A6), CD90.2 (Thy1.2, 53-2.1), CD69 (H1.2F3), NK1.1 (PK136), NK-CD49b (DX5), CD11b (M1/70), CD44 (IM7), Ly-6G (1A8), IL-17A (TC11-18H10), IFN-γ (XMG1.2), TNF (MP6-XT22); eBioscience (San Diego, CA): CD25 (PC61.5), MHC II (M5/114.15.2), F4/80 (BM8), Ly-6G (RB6-8C5); AbD Serotech (Raleigh, NC): 7/4 (Ly-6B.2); BioLegend (San Diego, CA): TCR Vγ1.1 and Vγ1.2 (4B2.9). enzyme-linked immunosorbent assay kits for IL-12p70, IFN-γ, TNF, IL-2, were purchased from BD Biosciences, for IL-17A was purchased from R&D Systems (Minneapolis, MN) and for IL-23p19 was purchased from eBioscience.
BAL fluid processing. Lungs were lavaged in situ with 5 ml of physiological buffer saline, and the BAL fluid was centrifuged at a low speed of 1500 r.p.m. at 4 °C for 5 min. The cellular pellet was washed, and cells were counted using a Z1 particle counter (Beckman Coulter, Brea, CA). BAL fluids were further centrifuged at a higher speed 20,000 g at 4 °C for 10 min and stored at −20 °C. Levels of IFN-γ protein in the BAL fluid were measured by enzyme-linked immunosorbent assay according to the manufacturer’s instruction.
Adoptive T-cell transfer. For T-cell transfer experiments, splenocytes were enriched using Nylon wool column as described earlier.47 Enriched T cells (∼106) were adoptively transferred intravenously by retro-orbital injection into recipient (TCRβδ−/−) mice.
Immune cell depletion. The following monoclonal antibodies were purchased from BioXCell (West Lebanon, NH): anti-NK1.1 clone PK136, anti-CD8 clone 2.43, and anti-CD4 clone GK1.5. Mice were treated with 50 ug anti-NK1.1, 500 ug anti-CD8, 200 ug anti-CD4, or control immunoglobulin G. All antibodies were administered intraperitoneally, and depletion was confirmed by flow cytometry.
Cytokine neutralization. IL-17A and IL-17E neutralization25 were carried out in WT mice by intraperitoneal injection of 200 μg of either anti-mouse IL-17A or anti-mouse IL-17E mAbs. Mouse or rat immunoglobulin G was used as control in separate group before SEA challenge.
Tissue processing and cell isolation. Lung tissue was perfused with physiological buffer saline -heparin (75 U ml−1), cut into small pieces, and incubated in the presence of 1.3 mM EDTA at 37 °C for 30 min, washed, followed by digestion with collagenase from Clostridium histolyticum IV (150 U ml−1; Sigma-Aldrich, St Louis, MO) for 1 h at 37 °C. Subsequently, digested lung tissues were crushed through nylon mesh cell strainers (BD Biosciences) and partitioned between 44% and 67% Percoll gradient to obtain lymphocytes at the interface. Spleens, inguinal, axillary, branchial, and mediastinal lymph nodes were homogenized into single-cell suspension by crushing them through nylon mesh cell strainers. Spleen cells were treated with ammonium chloride to lyse red blood cells. Single-cell suspensions from different tissues were washed with BSS and counted using a Z1 particle counter (Beckman Coulter).
In vitro cell culture. For in vitro stimulation, cells (106) were cultured for 5 h or the indicated time at 37 °C and 5% CO2 in 200 μl complete tumor medium, consisting of modified Eagle’s medium with 5% fetal bovine serum, amino acids, salts, and antibiotics. Cells were stimulated with media alone or PMA (50 ng ml−1; Calbiochem, Darmstadt, Germany) plus ionomycin (1 μg ml−1) (Invitrogen, San Diego, CA) and brefeldin A (BFA; 5 μg ml−1; Calbiochem) and stained for intracellular cytokines.
Flow cytometry. Surface and intracellular staining was performed as described previously.48 Briefly, cells were stained with primary Abs on ice for 30 min, in the presence of a blocking solution containing 5% normal mouse serum (Sigma-Aldrich), 10 μg ml−1 human γ-globulin (Sigma-Aldrich), and 0.1% sodium azide in culture supernatant from the 2.4.G.2 hybridoma (anti-FcR Abs).49 If secondary incubation was necessary, cells were washed and resuspended in wash buffer, and incubated on ice with streptavidin-conjugated flurochrome for 30 min. For intracellular cytokine staining, the cells were stained with primary antibodies, washed, and fixed with 2% paraformaldehyde in BSS. The cells were placed in permeabilization buffer (0.25% saponin in wash buffer) for 10 min and stained for intracellular staining with IL-17A, IFN-γ, and TNF or an isotype control. After staining, cells were washed in wash buffer containing 3% fetal bovine serum and 0.1% sodium azide in BSS. Flow cytometery was performed on a FACS-LSRII (BD Biosciences), and data were analyzed using FlowJo software (Tree Star, Ashland, OR).
Quantitative real-time reverse transcriptase–PCR. Total RNA was isolated from lung cells (percoll purified) from 2 h vehicle and SEA-immunized mice by RNeasy mini kit (Quiagen, Valencia, CA). RNA samples (100 ng) were reverse transcribed into cDNA using a High-Capacity cDNA Archive Kit (Applied Biosystems). mRNA expression level of target genes and the endogenous control gene HPRT1 were assessed by real-time PCR on 7300 Real Time PCR System (Applied Biosystems). The expression levels of target genes: IL-1β (Mm00434228m1), IL-18 (Mm00434225m1), IL-23p19 (Mm01160011g1) were calculated by normalization to HPRT1(Mm01545399m1) (Applied Biosystems).
Statistical analysis. A two-tailed Student’s unpaired t-test was used for data analyses, with values of P<0.05 used as the significance threshold. All statistical analyses were performed using Microsoft Excel and Prism-GraphPad (La Jolla, CA).
References
Akira, S., Takeda, K. & Kaisho, T. Toll-like receptors: critical proteins linking innate and acquired immunity. Nat Immunol 2, 675–680 (2001).
Medzhitov, R. & Janeway, C.A. Innate immunity: the virtues of a nonclonal system of recognition. Cell 91, 295–298 (1997).
Herman, A., Kappler, J.W., Marrack, P. & Pullen, A.M. Superantigens: mechanism of T-cell stimulation and role in immune responses. Annu. Rev. Immunol. 9, 745–772 (1991).
Herz, U. et al. Airway exposure to bacterial superantigen (SEB) induces lymphocyte-dependent airway inflammation associated with increased airway responsiveness—a model for non-allergic asthma. Eur. J. Immunol. 29, 1021–1031 (1999).
Muralimohan, G., Rossi, R.J., Guernsey, L.A., Thrall, R.S. & Vella, A.T. Inhalation of Staphylococcus aureus enterotoxin A induces IFN-gamma and CD8 T cell-dependent airway and interstitial lung pathology in mice. J. Immunol. 181, 3698–3705 (2008).
Fernandez, S., Cisney, E.D., Hall, S.I. & Ulrich, R.G. Nasal immunity to staphylococcal toxic shock is controlled by the nasopharynx-associated lymphoid tissue. Clin. Vaccine Immunol. 18, 667–675 (2011).
Bachert, C. et al. Presence of IL-5 protein and IgE antibodies to staphylococcal enterotoxins in nasal polyps is associated with comorbid asthma. J. Allergy Clin. Immunol. 126, 962–968 968 e961-966 (2010).
Corriveau, M.N., Zhang, N., Holtappels, G., Van Roy, N. & Bachert, C. Detection of Staphylococcus aureus in nasal tissue with peptide nucleic acid-fluorescence in situ hybridization. Am. J. Rhinol. Allergy 23, 461–465 (2009).
Hauk, P.J., Wenzel, S.E., Trumble, A.E., Szefler, S.J. & Leung, D.Y. Increased T-cell receptor vbeta8+ T cells in bronchoalveolar lavage fluid of subjects with poorly controlled asthma: a potential role for microbial superantigens. J. Allergy Clin. Immunol. 104, 37–45 (1999).
Hodges, E. et al. T cell receptor (TCR) Vbeta gene usage in bronchoalveolar lavage and peripheral blood T cells from asthmatic and normal subjects. Clin. Exp. Immunol. 112, 363–374 (1998).
Weber, R., Keerl, R., Hochapfel, F., Draf, W. & Toffel, P.H. Packing in endonasal surgery. Am. J. Otolaryngol. 22, 306–320 (2001).
Weber, M.A. et al. Infection and sudden unexpected death in infancy: a systematic retrospective case review. Lancet 371, 1848–1853 (2008).
Highet, A.R. & Goldwater, P.N. Staphylococcal enterotoxin genes are common in Staphylococcus aureus intestinal flora in sudden infant death syndrome (SIDS) and live comparison infants. FEMS Immunol. Med. Microbiol. 57, 151–155 (2009).
Lockhart, E., Green, A.M. & Flynn, J.L. IL-17 production is dominated by gammadelta T cells rather than CD4 T cells during Mycobacterium tuberculosis infection. J. Immunol. 177, 4662–4669 (2006).
Ye, P. et al. Requirement of interleukin 17 receptor signaling for lung CXC chemokine and granulocyte colony-stimulating factor expression, neutrophil recruitment, and host defense. J. Exp. Med. 194, 519–527 (2001).
Callahan, J.E., Herman, A., Kappler, J.W. & Marrack, P. Stimulation of B10.BR T cells with superantigenic staphylococcal toxins. J. Immunol. 144, 2473–2479 (1990).
Catalona, W.J., Ratliff, T.L. & McCool, R.E. gamma-Interferon induced by S. aureus protein A augments natural killing and ADCC. Nature 291, 77–79 (1981).
Bhandari, V. & Elias, J.A. Cytokines in tolerance to hyperoxia-induced injury in the developing and adult lung. Free Radic. Biol. Med. 41, 4–18 (2006).
Matute-Bello, G., Frevert, C.W. & Martin, T.R. Animal models of acute lung injury. Am. J. Physiol. Lung Cell. Mol. Physiol. 295, L379–L399 (2008).
Miller, E.J., Cohen, A.B. & Peterson, B.T. Peptide inhibitor of interleukin-8 (IL-8) reduces staphylococcal enterotoxin-A (SEA) induced neutrophil trafficking to the lung. Inflamm. Res. 45, 393–397 (1996).
Parsons, P.E., Gillespie, M.M., Moore, E.E., Moore, F.A. & Worthen, G.S. Neutrophil response to endotoxin in the adult respiratory distress syndrome: role of CD14. Am. J. Respir. Cell Mol. Biol. 13, 152–160 (1995).
Hirsch, S. & Gordon, S. Polymorphic expression of a neutrophil differentiation antigen revealed by monoclonal antibody 7/4. Immunogenetics 18, 229–239 (1983).
Tsou, C.L. et al. Critical roles for CCR2 and MCP-3 in monocyte mobilization from bone marrow and recruitment to inflammatory sites. J. Clin. Invest. 117, 902–909 (2007).
Kolls, J.K. & Linden, A. Interleukin-17 family members and inflammation. Immunity 21, 467–476 (2004).
Rickel, E.A. et al. Identification of functional roles for both IL-17RB and IL-17RA in mediating IL-25-induced activities. J. Immunol. 181, 4299–4310 (2008).
Ribot, J.C. et al. CD27 is a thymic determinant of the balance between interferon-gamma- and interleukin 17-producing gammadelta T cell subsets. Nat. Immunol. 10, 427–436 (2009).
Carding, S.R. & Egan, P.J. Gammadelta T cells: functional plasticity and heterogeneity. Nat. Rev. Immunol. 2, 336–345 (2002).
Janeway, C.A. Approaching the asymptote? Evolution and revolution in immunology. Cold Spring Harb. Symp. Quant. Biol. 54 (Pt 1), 1–13 (1989).
Medzhitov, R., Preston-Hurlburt, P. & Janeway, C.A. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature 388, 394–397 (1997).
Seth, A. et al. Binary and ternary complexes between T-cell receptor, class II MHC and superantigen in vitro. Nature 369, 324–327 (1994).
Scharton, T.M. & Scott, P. Natural killer cells are a source of interferon gamma that drives differentiation of CD4+ T cell subsets and induces early resistance to Leishmania major in mice. J. Exp. Med. 178, 567–577 (1993).
Fraser, J.D. & Proft, T. The bacterial superantigen and superantigen-like proteins. Immunol. Rev. 225, 226–243 (2008).
Peavy, D.L., Adler, W.H. & Smith, R.T. The mitogenic effects of endotoxin and staphylococcal enterotoxin B on mouse spleen cells and human peripheral lymphocytes. J. Immunol. 105, 1453–1458 (1970).
Laan, M. et al. Neutrophil recruitment by human IL-17 via C-X-C chemokine release in the airways. J. Immunol. 162, 2347–2352 (1999).
Shibata, K., Yamada, H., Hara, H., Kishihara, K. & Yoshikai, Y. Resident Vdelta1+ gammadelta T cells control early infiltration of neutrophils after Escherichia coli infection via IL-17 production. J. Immunol. 178, 4466–4472 (2007).
Hamada, S. et al. IL-17A produced by gammadelta T cells plays a critical role in innate immunity against listeria monocytogenes infection in the liver. J. Immunol. 181, 3456–3463 (2008).
Simonian, P.L. et al. IL-17A-expressing T cells are essential for bacterial clearance in a murine model of hypersensitivity pneumonitis. J. Immunol. 182, 6540–6549 (2009).
Cruz, A. et al. Cutting edge: IFN-gamma regulates the induction and expansion of IL-17-producing CD4 T cells during mycobacterial infection. J. Immunol. 177, 1416–1420 (2006).
Janis, E.M., Kaufmann, S.H., Schwartz, R.H. & Pardoll, D.M. Activation of gamma delta T cells in the primary immune response to Mycobacterium tuberculosis. Science 244, 713–716 (1989).
Laurence, A. et al. Interleukin-2 signaling via STAT5 constrains T helper 17 cell generation. Immunity 26, 371–381 (2007).
Ribot, J.C., Debarros, A., Mancio-Silva, L., Pamplona, A. & Silva-Santos, B. B7-CD28 costimulatory signals control the survival and proliferation of murine and human gammadelta T cells via IL-2 production. J. Immunol. 189, 1202–1208 (2012).
Aggarwal, S., Ghilardi, N., Xie, M.H., de Sauvage, F.J. & Gurney, A.L. Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17. J. Biol. Chem. 278, 1910–1914 (2003).
van de Veerdonk, F.L. et al. Mycobacterium tuberculosis induces IL-17A responses through TLR4 and dectin-1 and is critically dependent on endogenous IL-1. J. Leukoc. Biol. 88, 227–232 (2010).
Packiam, M. et al. Protective role of Toll-like receptor 4 in experimental gonococcal infection of female mice. Mucosal Immunol. 5, 19–29 (2011).
McAleer, J.P. et al. Potent intestinal Th17 priming through peripheral lipopolysaccharide-based immunization. J. Leukoc. Biol. 88, 21–31 (2010).
Moreira, A.P. et al. The protective role of TLR6 in a mouse model of asthma is mediated by IL-23 and IL-17A. J. Clin. Invest. 121, 4420–4432 (2011).
Trizio, D. & Cudkowicz, G. Separation of T and B lymphocytes by nylon wool columns: evaluation of efficacy by functional assays in vivo. J. Immunol. 113, 1093–1097 (1974).
McAleer, J.P., Zammit, D.J., Lefrancois, L., Rossi, R.J. & Vella, A.T. The lipopolysaccharide adjuvant effect on T cells relies on nonoverlapping contributions from the MyD88 pathway and CD11c+ cells. J. Immunol. 179, 6524–6535 (2007).
Unkeless, J.C. Characterization of a monoclonal antibody directed against mouse macrophage and lymphocyte Fc receptors. J. Exp. Med. 150, 580–596 (1979).
Acknowledgements
This work was supported by NIH grant 1PO1-AI05172 (LL) Project 3 (ATV), UO1 AI 095544 (LL) and grant PF-11-152-01-LIB from the American Cancer Society (SLC).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
ALB is employed by and owns stock in Amgen. The remaining authors declared no conflict of interest.
Additional information
SUPPLEMENTARY MATERIAL is linked to the online version of the paper
Supplementary information
Rights and permissions
About this article
Cite this article
Kumar, S., Colpitts, S., Ménoret, A. et al. Rapid αβ T-cell responses orchestrate innate immunity in response to Staphylococcal enterotoxin A. Mucosal Immunol 6, 1006–1015 (2013). https://doi.org/10.1038/mi.2012.138
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/mi.2012.138